Early caudate involvement marks a Lewy body spectrum phenotype in parkinsonism: a 5-year longitudinal study
4 affiliations
- 1Neurology Clinic, San Pio Hospital
- 2CUNY School of Medicine
- 3Department of Neurology, Zucker School of Medicine, Hofstra/Northwell Health
- 4Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara
Abstract
Background: Parkinsonian syndromes are increasingly recognized as part of a heterogeneous spectrum of Lewy body diseases, ranging from Parkinson’s disease (PD) to dementia with Lewy bodies (DLB). Identifying early markers of clinical heterogeneity remains challenging.
Objective: To investigate whether striatal dopaminergic denervation patterns on DAT-SPECT are associated with distinct clinical phenotypes and long-term cognitive trajectories in early parkinsonism.
Methods: Twenty-eight patients with early parkinsonism fulfilling clinical diagnostic criteria for PD underwent DAT-SPECT and were classified according to the topography of dopaminergic denervation into isolated putaminal involvement (P group) or combined putaminal and caudate involvement (PC group). Motor, neuropsychiatric, and cognitive assessments, including the MoCA, were performed at baseline and after 5 years.
Results: At baseline, patients with caudate involvement ( n = 16) showed greater motor impairment and a higher prevalence of psychiatric symptoms than the P group. Early cognitive impairment was observed in 32% of the PC group versus 0% of the P group. Over 5 years, the PC group showed greater cognitive deterioration, with 83% scoring below the cognitive impairment threshold compared with 9% in the P group. Visual hallucinations developed in a subset of PC patients during follow-up.
Conclusion: Early caudate dopaminergic denervation identifies a parkinsonian phenotype associated with greater motor severity, neuropsychiatric manifestations, and accelerated cognitive decline. Its longitudinal evolution may reflect a trajectory toward the cognitive and neuropsychiatric end of the Lewy body disease spectrum, including a DLB-like phenotype. DAT-SPECT may provide prognostic information beyond its diagnostic utility.
Related
- A longitudinal study of rotenone-induced Parkinsonism in mice
- Cerebral Attack With Cortical-Leptomeningeal Involvement and Seizures in AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
- Kidney involvement in idiopathic multicentric Castleman disease-TAFRO syndrome: clinical spectrum, pathology and outcomes.
- Central adiposity is associated with the severity and multiligamentous involvement of ossification of the posterior longitudinal ligament.
- CLINICAL SPECTRUM AND ORGAN INVOLVEMENT IN TELOMERE BIOLOGY DISORDERS: A SINGLE-CENTRE COHORT
BibTeX
@article{varanese2026early,
title = {{Early caudate involvement marks a Lewy body spectrum phenotype in parkinsonism: a 5-year longitudinal study}},
author = {Sara Varanese and Maria Pia Buongarzone and Stefano Viola and Maria Felice Ghilardi and Alessandro di Rocco and Rino Speranza and Alessia Masotino and Christian Durante and Laura Bonanni},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1895109},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1895109/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Early caudate involvement marks a Lewy body spectrum phenotype in parkinsonism: a 5-year longitudinal study
AU - Sara Varanese
AU - Maria Pia Buongarzone
AU - Stefano Viola
AU - Maria Felice Ghilardi
AU - Alessandro di Rocco
AU - Rino Speranza
AU - Alessia Masotino
AU - Christian Durante
AU - Laura Bonanni
PY - 2026
DA - 2026/10/16
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1895109
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1895109/full
AB - Background: Parkinsonian syndromes are increasingly recognized as part of a heterogeneous spectrum of Lewy body diseases, ranging from Parkinson’s disease (PD) to dementia with Lewy bodies (DLB). Identifying early markers of clinical heterogeneity remains challenging. Objective: To investigate whether striatal dopaminergic denervation patterns on DAT-SPECT are associated with distinct clinical phenotypes and long-term cognitive trajectories in early parkinsonism. Methods: Twenty-eight patients with early parkinsonism fulfilling clinical diagnostic criteria for PD underwent DAT-SPECT and were classified according to the topography of dopaminergic denervation into isolated putaminal involvement (P group) or combined putaminal and caudate involvement (PC group). Motor, neuropsychiatric, and cognitive assessments, including the MoCA, were performed at baseline and after 5 years. Results: At baseline, patients with caudate involvement ( n = 16) showed greater motor impairment and a higher prevalence of psychiatric symptoms than the P group. Early cognitive impairment was observed in 32% of the PC group versus 0% of the P group. Over 5 years, the PC group showed greater cognitive deterioration, with 83% scoring below the cognitive impairment threshold compared with 9% in the P group. Visual hallucinations developed in a subset of PC patients during follow-up. Conclusion: Early caudate dopaminergic denervation identifies a parkinsonian phenotype associated with greater motor severity, neuropsychiatric manifestations, and accelerated cognitive decline. Its longitudinal evolution may reflect a trajectory toward the cognitive and neuropsychiatric end of the Lewy body disease spectrum, including a DLB-like phenotype. DAT-SPECT may provide prognostic information beyond its diagnostic utility.
SN - 1664-2295
ER -